Possible impact of the CYP2D6*10 polymorphism on the nonlinear pharmacokinetic parameter estimates of paroxetine in Japanese patients with major depressive disorders

• Príomhchruthaitheoirí: Saruwatari J (Údar), Nakashima H (Údar), Tsuchimine S (Údar), Nishimura M (Údar), Ogusu N (Údar), Yasui-Furukori N (Údar)
• Formáid: LEABHAR
• Foilsithe / Cruthaithe: Dove Medical Press, 2014-04-01T00:00:00Z.
• Ábhair: article
• Rochtain ar líne: Connect to this object online.

Junji Saruwatari,1 Hiroo Nakashima,1 Shoko Tsuchimine,2 Miki Nishimura,1 Naoki Ogusu,1 Norio Yasui-Furukori21Division of Pharmacology and Therapeutics, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan; 2Department of Neuropsychiatry, Graduate School of Medicine, Hiros...